BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, Li AM, Shi MF, Zou L. Interruption of HBV intrauterine transmission: A clinical study. World J Gastroenterol 2003; 9(7): 1501-1503 [PMID: 12854150 DOI: 10.3748/wjg.v9.i7.1501] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 83] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Unal ER, Lazenby GB, Lintzenich AE, Simpson KN, Newman R, Goetzl L. Cost-effectiveness of maternal treatment to prevent perinatal hepatitis B virus transmission. Obstet Gynecol 2011;118:655-62. [PMID: 21860297 DOI: 10.1097/AOG.0b013e31822ad2c2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
2 Chen Y, Sze J, He ML. HBV cccDNA in patients’ sera as an indicator for HBV reactivation and an early signal of liver damage. World J Gastroenterol 2004; 10(1): 82-85 [PMID: 14695774 DOI: 10.3748/wjg.v10.i1.82] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
3 Komatsu H, Inui A. Hepatitis B virus infection in children. Expert Rev Anti Infect Ther. 2015;13:427-450. [PMID: 25724218 DOI: 10.1586/14787210.2015.1019867] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
4 Tavakolpour S, Darvishi M, Mirsafaei HS, Ghasemiadl M. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review. Infect Dis (Lond). 2018;50:95-106. [PMID: 29020844 DOI: 10.1080/23744235.2017.1384957] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
5 Sali S, Darvishi M, GhasemiAdl M, Akhlaghdoust M, Mirzazadeh A, Behjati SE, Sheikh-Zeinolabedini H, Shokouhi S, Tavakolpour S. Comparing the Efficacy and Safety of Treating Chronic Hepatitis B Infection during Pregnancy with Lamivudine, Telbivudine, and Tenofovir: A Meta-analysis. J Clin Transl Hepatol 2019;7:197-212. [PMID: 31608211 DOI: 10.14218/JCTH.2019.00021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Chen Z, Zeng M, Liu D, Wu L, Zhang L. Antenatal administration of hepatitis B immunoglobulin and hepatitis B vaccine to prevent mother to child transmission in hepatitis B virus surface antigen positive pregnant women: A systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e19886. [PMID: 32312015 DOI: 10.1097/MD.0000000000019886] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wu Y, Liu J, Feng Y, Fu S, Ji F, Ge L, Yao N, Luo X, Zhao Y, Chen Y, Yang Y, Chen T. Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis. Hepatol Int 2020;14:180-9. [PMID: 32193814 DOI: 10.1007/s12072-020-10026-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
8 Wang W, Wang J, Dang S, Zhuang G. Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus. PeerJ 2016;4:e1709. [PMID: 27042389 DOI: 10.7717/peerj.1709] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
9 Nayeri UA, Werner EF, Han CS, Pettker CM, Funai EF, Thung SF. Antenatal lamivudine to reduce perinatal hepatitis B transmission: a cost-effectiveness analysis. American Journal of Obstetrics and Gynecology 2012;207:231.e1-7. [DOI: 10.1016/j.ajog.2012.06.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
10 Elefsiniotis IS, Glynou I, Brokalaki H, Magaziotou I, Pantazis KD, Fotiou A, Liosis G, Kada H, Saroglou G. Serological and virological profile of chronic HBV infected women at reproductive age in Greece. A two-year single center study. Eur J Obstet Gynecol Reprod Biol. 2007;132:200-203. [PMID: 17030083 DOI: 10.1016/j.ejogrb.2006.08.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
11 Zhao LS. To eliminated hepatitis B virus vertical transmission: the resolved and unresolved. Shijie Huaren Xiaohua Zazhi 2007; 15(15): 1677-1681 [DOI: 10.11569/wcjd.v15.i15.1677] [Reference Citation Analysis]
12 Zhang L, Gui XE, Wang B, Fan JY, Cao Q, Mullane K, Liang XL. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates. BMC Infect Dis 2016;16:408. [PMID: 27515176 DOI: 10.1186/s12879-016-1754-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
13 Leung N. Lamivudine for chronic hepatitis B. Expert Rev Anti Infect Ther. 2004;2:173-180. [PMID: 15482184 DOI: 10.1586/14787210.2.2.173] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
14 Liu S, Dong Y, Zhang L, Li M, Wo J, Lu L, Chen Z, Wang Y, Ruan B. Influence of HBV gene heterogeneity on the failure of immunization with HBV vaccines in eastern China. Arch Virol 2009;154:437-43. [DOI: 10.1007/s00705-009-0315-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
15 Siemieniuk RA, Foroutan F, Mirza R, Mah Ming J, Alexander PE, Agarwal A, Lesi O, Merglen A, Chang Y, Zhang Y. Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis. BMJ Open. 2017;7:e019022. [PMID: 28893758 DOI: 10.1136/bmjopen-2017-019022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
16 de Waal N, Rabie H, Bester R, Cotton MF. Mass needle stick injury in children from the Western cape. J Trop Pediatr 2006;52:192-6. [PMID: 16291833 DOI: 10.1093/tropej/fmi094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
17 Hawkins D, Blott M, Clayden P, de Ruiter A, Foster G, Gilling-Smith C, Gosrani B, Lyall H, Mercey D, Newell ML, O'Shea S, Smith R, Sunderland J, Wood C, Taylor G; BHIVA Guidelines Writing Committee. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV. HIV Med 2005;6 Suppl 2:107-48. [PMID: 16033339 DOI: 10.1111/j.1468-1293.2005.00302.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
18 Han L, Zhang HW, Xie JX, Zhang Q, Wang HY, Cao GW. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol 2011; 17(38): 4321-4333 [PMID: 22090789 DOI: 10.3748/wjg.v17.i38.4321] [Cited by in CrossRef: 93] [Cited by in F6Publishing: 83] [Article Influence: 8.5] [Reference Citation Analysis]
19 Guo Y, Liu J, Meng L, Meina H, Du Y. Survey of HBsAg-positive pregnant women and their infants regarding measures to prevent maternal-infantile transmission. BMC Infect Dis 2010;10:26. [PMID: 20156338 DOI: 10.1186/1471-2334-10-26] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
20 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(7): 1656-1658 [DOI: 10.11569/wcjd.v12.i7.1656] [Reference Citation Analysis]
21 Brown RS Jr, McMahon BJ, Lok AS, Wong JB, Ahmed AT, Mouchli MA, Wang Z, Prokop LJ, Murad MH, Mohammed K. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis. Hepatology 2016;63:319-33. [PMID: 26565396 DOI: 10.1002/hep.28302] [Cited by in Crossref: 207] [Cited by in F6Publishing: 181] [Article Influence: 34.5] [Reference Citation Analysis]
22 Peters MG. Special populations with hepatitis B virus infection. Hepatology 2009;49:S146-55. [PMID: 19399810 DOI: 10.1002/hep.22965] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
23 Zheng PY, Tang FA, Lu GF, Bai JX. Prevention of vertical transmission and treatment of chronic hepatitis B. Shijie Huaren Xiaohua Zazhi 2007; 15(1): 1-6 [DOI: 10.11569/wcjd.v15.i1.1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev. 2006;CD004790. [PMID: 16625613 DOI: 10.1002/14651858.cd004790.pub2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
25 Jin H, Zhao Y, Tan Z, Zhang X, Zhao Y, Wang B, Liu P. Immunization interventions to interrupt hepatitis B virus mother-to-child transmission: a meta-analysis of randomized controlled trials. BMC Pediatr 2014;14:307. [PMID: 25526664 DOI: 10.1186/s12887-014-0307-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
26 Ma L, Alla NR, Li X, Mynbaev OA, Shi Z. Mother-to-child transmission of HBV: review of current clinical management and prevention strategies: Mother-to-child transmission of HBV. Rev Med Virol 2014;24:396-406. [DOI: 10.1002/rmv.1801] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
27 Lee YS, Lee HS, Kim JH, Chang SW, Hyun MH, Bak H, Kim S, Lee MJ, Lee CU, Jung YK, Seo YS, Yim HJ, Yeon JE, Um SH, Byun KS. Role of tenofovir disoproxil fumarate in prevention of perinatal transmission of hepatitis B virus from mother to child: a systematic review and meta-analysis. Korean J Intern Med 2021;36:76-85. [PMID: 31878771 DOI: 10.3904/kjim.2018.465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Utoo BT. Hepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria. Afr Health Sci 2013;13:1139-43. [PMID: 24940343 DOI: 10.4314/ahs.v13i4.39] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
29 Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64:933-945. [PMID: 26658682 DOI: 10.1016/j.jhep.2015.11.030] [Cited by in Crossref: 92] [Cited by in F6Publishing: 54] [Article Influence: 13.1] [Reference Citation Analysis]
30 Tiwari A, Sankhyan A, Khanna N, Sinha S. Enhanced periplasmic expression of high affinity humanized scFv against Hepatitis B surface antigen by codon optimization. Protein Expression and Purification 2010;74:272-9. [DOI: 10.1016/j.pep.2010.06.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
31 Bierhoff M, Angkurawaranon C, Rijken MJ, Sriprawa K, Kobphan P, Nosten FN, van Vugt M, McGready R, Devine A. Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis. BMC Pregnancy Childbirth 2021;21:157. [PMID: 33618698 DOI: 10.1186/s12884-021-03612-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Eke AC, Eleje GU, Eke UA, Xia Y, Liu J. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus. Cochrane Database Syst Rev. 2017;2:CD008545. [PMID: 28188612 DOI: 10.1002/14651858.cd008545.pub2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
33 Yu M, Ji Y, Jiang H, Ju L, Wu K, Kan N. Efficacy of peripartum antiviral treatment for hepatic failure due to hepatitis B virus. Int J Gynaecol Obstet 2011;114:33-6. [PMID: 21592475 DOI: 10.1016/j.ijgo.2011.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
34 Tiwari A, Dutta D, Khanna N, Acharya SK, Sinha S. Generation and characterization of high affinity humanized fab against hepatitis B surface antigen. Mol Biotechnol. 2009;43:29-40. [PMID: 19326261 DOI: 10.1007/s12033-009-9165-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
35 Yuan J, Lin J, Xu A, Li H, Hu B, Chen J, Yao J, Dong H, Jiang M. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepat. 2006;13:597-604. [PMID: 16907846 DOI: 10.1111/j.1365-2893.2006.00738.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 3.3] [Reference Citation Analysis]
36 Fan L, Owusu-Edusei K Jr, Schillie SF, Murphy TV. Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral load. Obstet Gynecol. 2014;123:929-937. [PMID: 24785842 DOI: 10.1097/aog.0000000000000124] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
37 Tajiri K, Shimizu Y. Unsolved problems and future perspectives of hepatitis B virus vaccination. World J Gastroenterol 2015;21:7074-83. [PMID: 26109794 DOI: 10.3748/wjg.v21.i23.7074] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
38 Bacq Y. Hépatite virale B et Grossesse. Gastroentérologie Clinique et Biologique 2008;32:S12-9. [DOI: 10.1016/s0399-8320(08)73260-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
39 Hu KQ. A Practical Approach to Management of Chronic Hepatitis B. Int J Med Sci 2005;2:17-23. [PMID: 15968335 DOI: 10.7150/ijms.2.17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
40 Zhang Z, Chen C, Li Z, Wu YH, Xiao XM. Individualized management of pregnant women with high hepatitis B virus DNA levels. World J Gastroenterol 2014; 20(34): 12056-12061 [PMID: 25232243 DOI: 10.3748/wjg.v20.i34.12056] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
41 Greenup AJ, Tan PK, Nguyen V, Glass A, Davison S, Chatterjee U, Holdaway S, Samarasinghe D, Jackson K, Locarnini SA. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. J Hepatol. 2014;61:502-507. [PMID: 24801414 DOI: 10.1016/j.jhep.2014.04.038] [Cited by in Crossref: 127] [Cited by in F6Publishing: 111] [Article Influence: 15.9] [Reference Citation Analysis]
42 Xu Q, Xiao L, Lu XB, Zhang YX, Cai X. A randomized controlled clinical trial: Interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World J Gastroenterol 2006; 12(21): 3434-3437 [PMID: 16733865 DOI: 10.3748/wjg.v12.i21.3434] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
43 Dusheiko G. Towards the elimination and eradication of hepatitis B. Journal of Virus Eradication 2015;1:4-12. [DOI: 10.1016/s2055-6640(20)31151-1] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
44 Soni S, Badawy SZ. Hepatitis B Therapy in Pregnancy. Curr Hepat Rep. 2010;9:197-204. [PMID: 20337200 DOI: 10.1007/s11901-010-0059-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
45 Zhao Y, Jin H, Zhang X, Wang B, Liu P. Viral hepatitis vaccination during pregnancy. Hum Vaccin Immunother 2016;12:894-902. [PMID: 26833263 DOI: 10.1080/21645515.2015.1132129] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
46 Gambarin-Gelwan M. Hepatitis B in pregnancy. Clin Liver Dis. 2007;11:945-963, x. [PMID: 17981236 DOI: 10.1016/j.cld.2007.08.004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 4.4] [Reference Citation Analysis]
47 Polo Rodríguez R, Muñoz Galligo E, Iribarren JA, Domingo Pedrol P, Leyes García M, Maiques Montesinos V, Miralles Martín P, Noguera Julian A, Ocampo Hernández A, Péres Bares ML, López Rojano M, Suy Franch A, Viñuela Beneitez MC, González Tomé MI; Panel de Expertos de la Secretaría del Plan Nacional sobre el Sida (SPNS)., Grupo de Estudio de Sida (GeSIDA)., Sociedad Española de Ginecología y Obstetricia (SEGO)., Sociedad Española de Infectología Pediátrica (SEIP). [Consensus statement on monitoring of HIV: pregnancy, birth, and prevention of mother-to-child transmission]. Enferm Infecc Microbiol Clin 2014;32:310.e1-310.e33. [PMID: 24484733 DOI: 10.1016/j.eimc.2013.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
48 Bzowej NH. Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant. Curr Hepat Rep. 2012;11:82-89. [PMID: 22707918 DOI: 10.1007/s11901-012-0130-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
49 Chen HM, Bai XF, Huang CX, Li GY, Hong S. Construction and expression of eukaryotic vector bearing fusion gene of HBV PreS2S and Fc fragment. Shijie Huaren Xiaohua Zazhi 2004; 12(5): 1081-1084 [DOI: 10.11569/wcjd.v12.i5.1081] [Reference Citation Analysis]
50 Tiwari A, Khanna N, Acharya SK, Sinha S. Humanization of high affinity anti-HBs antibody by using human consensus sequence and modification of selected minimal positional template and packing residues. Vaccine 2009;27:2356-66. [PMID: 19428851 DOI: 10.1016/j.vaccine.2009.02.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
51 Eke AC, Eke UA, Okafor CI, Ezebialu IU, Ogbuagu C. Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting. Virol J 2011;8:12. [PMID: 21226907 DOI: 10.1186/1743-422X-8-12] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
52 Bose B, Khanna N, Acharya SK, Sinha S. High affinity mouse-human chimeric Fab against hepatitis B surface antigen. World J Gastroenterol 2005;11:7569-78. [PMID: 16437680 DOI: 10.3748/wjg.v11.i48.7569] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
53 Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron LG, Maley MW, Ayres A, Locarnini SA, Levy MT. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009;190:489-92. [PMID: 19413519 DOI: 10.5694/j.1326-5377.2009.tb02524.x] [Cited by in Crossref: 234] [Cited by in F6Publishing: 220] [Article Influence: 18.0] [Reference Citation Analysis]
54 Zhao P, Qian X, Su C, Yang X, Bai X. Lamivudine vs placebo or no treatment in preventing the transmission of hepatitis B virus during pregnancy: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg 2020;114:121-30. [PMID: 31703121 DOI: 10.1093/trstmh/trz078] [Reference Citation Analysis]
55 Zuckerman JN. Review: hepatitis B immune globulin for prevention of hepatitis B infection. J Med Virol. 2007;79:919-921. [PMID: 17516515 DOI: 10.1002/jmv.20816] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
56 Lee YS, Bang SM, Lee YS. Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B. J Clin Med 2021;10:2320. [PMID: 34073357 DOI: 10.3390/jcm10112320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Pol S, Corouge M, Fontaine H. Hepatitis B virus infection and pregnancy. Clinics and Research in Hepatology and Gastroenterology 2011;35:618-22. [DOI: 10.1016/j.clinre.2011.03.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
58 Colomina-Rodríguez J, Bonanad-Boix S, Cervera-Sánchez J, Guerrero-Espejo A. [Prevention of intrauterine hepatitis B virus infection in invasive procedures: a case report]. An Pediatr (Barc) 2007;66:319-20. [PMID: 17349262 DOI: 10.1016/s1695-4033(07)70401-0] [Reference Citation Analysis]
59 Leung N. Chronic hepatitis B in Asian women of childbearing age. Hepatol Int. 2009;3 Suppl 1:24-31. [PMID: 19669243 DOI: 10.1007/s12072-009-9142-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
60 Wu Q, Huang H, Sun X, Pan M, He Y, Tan S, Zeng Y, Li L, Deng G, Yan Z, He D, Li J, Wang Y. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study. Clin Gastroenterol Hepatol. 2015;13:1170-1176. [PMID: 25251571 DOI: 10.1016/j.cgh.2014.08.043] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
61 Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, Teng BQ. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004; 10(21): 3215-3217 [PMID: 15457579 DOI: 10.3748/wjg.v10.i21.3215] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 62] [Article Influence: 3.6] [Reference Citation Analysis]
62 Visvanathan K, Dusheiko G, Giles M, Wong ML, Phung N, Walker S, Le S, Lim SG, Gane E, Ngu M, Hardikar W, Cowie B, Bowden S, Strasser S, Levy M, Sasaduesz J. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut 2016;65:340-50. [PMID: 26475631 DOI: 10.1136/gutjnl-2015-310317] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 8.8] [Reference Citation Analysis]
63 Yang YB, Li XM, Shi ZJ, Ma L. Pregnant woman with fulminant hepatic failure caused by hepatitis B virus infection: A case report. World J Gastroenterol 2004; 10(15): 2305-2306 [PMID: 15259091 DOI: 10.3748/wjg.v10.i15.2305] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
64 Njei B, Gupta N, Ewelukwa O, Ditah I, Foma M, Lim JK. Comparative efficacy of antiviral therapy in preventing vertical transmission of hepatitis B: a network meta-analysis. Liver Int. 2016;36:634-641. [PMID: 26352650 DOI: 10.1111/liv.12959] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
65 Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Hepatitis B vaccination during pregnancy for preventing infant infection. Cochrane Database Syst Rev 2014;:CD007879. [PMID: 25385500 DOI: 10.1002/14651858.CD007879.pub3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
66 Kar P, Sengupta A. Synthetic therapeutics for the treatment of hepatitis B during pregnancy. Expert Opin Pharmacother 2018;19:1771-8. [PMID: 30273073 DOI: 10.1080/14656566.2018.1527313] [Reference Citation Analysis]
67 Shao ZJ, Men K, Xu JQ, Xu DZ, Yan YP, Zhang JX. Effect of HBeAg on the hepatitis B virus vertical transmission in neonates. Shijie Huaren Xiaohua Zazhi 2004; 12(2): 298-301 [DOI: 10.11569/wcjd.v12.i2.298] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Hu Y, Yu H. Prevention strategies of mother-to-child transmission of hepatitis B virus (HBV) infection. Pediatr Investig 2020;4:133-7. [PMID: 32851357 DOI: 10.1002/ped4.12205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
69 Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, Zhang SL, Qiao FY, Campbell F, Chang CN, Gardner S, Atkins M. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009;16:94-103. [PMID: 19175878 DOI: 10.1111/j.1365-2893.2008.01056.x] [Cited by in Crossref: 259] [Cited by in F6Publishing: 238] [Article Influence: 18.5] [Reference Citation Analysis]
70 Deng M, Zhou X, Gao S, Yang SG, Wang B, Chen HZ, Ruan B. The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis. Virol J 2012;9:185. [PMID: 22947333 DOI: 10.1186/1743-422X-9-185] [Cited by in Crossref: 54] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
71 Lee C, Gong Y, Brok J, Boxall E, Gluud C. Cochrane review: Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Evid -Based Child Health 2007;2:67-155. [DOI: 10.1002/ebch.120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
72 Khalighinejad P, Alavian SM, Fesharaki MG, Jalilianhasanpour R. Lamivudine's efficacy and safety in preventing mother-to-child transmission of hepatitis B: A meta-analysis. Turk J Gastroenterol. 2019;30:66-74. [PMID: 30475212 DOI: 10.5152/tjg.2018.18148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
73 Chotiyaputta W, Lok AS. Role of antiviral therapy in the prevention of perinatal transmission of hepatitis B virus infection. J Viral Hepat. 2009;16:91-93. [PMID: 19175877 DOI: 10.1111/j.1365-2893.2008.01067.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
74 Shi Z, Li X, Ma L, Yang Y. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis. 2010;14:e622-e634. [PMID: 20106694 DOI: 10.1016/j.ijid.2009.09.008] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
75 Yi P, Chen R, Huang Y, Zhou RR, Fan XG. Management of mother-to-child transmission of hepatitis B virus: Propositions and challenges. J Clin Virol. 2016;77:32-39. [PMID: 26895227 DOI: 10.1016/j.jcv.2016.02.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
76 Rapti IN, Hadziyannis SJ. Treatment of special populations with chronic hepatitis B infection. Expert Review of Gastroenterology & Hepatology 2014;5:323-39. [DOI: 10.1586/egh.11.7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
77 Wang Z, Zeng J, Li T, Zheng X, Xu X, Ye X, Lu L, Zhu W, Yang B, Allain JP, Li C. Prevalence of hepatitis B surface antigen (HBsAg) in a blood donor population born prior to and after implementation of universal HBV vaccination in Shenzhen, China. BMC Infect Dis 2016;16:498. [PMID: 27647214 DOI: 10.1186/s12879-016-1834-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
78 Shi Z, Yang Y, Ma L, Li X, Schreiber A. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol. 2010;116:147-159. [PMID: 20567182 DOI: 10.1097/aog.0b013e3181e45951] [Cited by in Crossref: 120] [Cited by in F6Publishing: 39] [Article Influence: 10.0] [Reference Citation Analysis]
79 Tillmann HL. Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 2007; 13(1): 125-140 [PMID: 17206760 DOI: 10.3748/wjg.v13.i1.125] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
80 Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ. 2006;332:328-336. [PMID: 16443611 DOI: 10.1136/bmj.38719.435833.7c] [Cited by in Crossref: 253] [Cited by in F6Publishing: 85] [Article Influence: 15.8] [Reference Citation Analysis]
81 Xu H, Zeng T, Liu JY, Lei Y, Zhong S, Sheng YJ, Zhou Z, Ren H. Measures to reduce mother-to-child transmission of Hepatitis B virus in China: a meta-analysis. Dig Dis Sci 2014;59:242-58. [PMID: 24193353 DOI: 10.1007/s10620-013-2918-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
82 Yu M, Jiang Q, Ji Y, Jiang H, Wu K, Ju L, Tang X, Wu M. The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus. Eur J Clin Microbiol Infect Dis. 2012;31:2211-2218. [PMID: 22314409 DOI: 10.1007/s10096-012-1557-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
83 Song J, Yang F, Wang S, Tikande S, Deng Y, Tang W, Cao G. Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: A meta-analysis. J Viral Hepat 2019;26:397-406. [PMID: 30417469 DOI: 10.1111/jvh.13036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
84 Hung H, Chen H. Cost-Effectiveness Analysis of Prophylactic Lamivudine Use in Preventing Vertical Transmission of Hepatitis B Virus Infection: . PharmacoEconomics 2011;29:1063-73. [DOI: 10.2165/11586470-000000000-00000] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
85 Bierhoff M, Nelson KE, Guo N, Jia Y, Angkurawaranon C, Jittamala P, Carrara V, Watthanaworawit W, Ling C, Tongprasert F, van Vugt M, Rijken M, Nosten F, McGready R, Ehrhardt S, Thio CL. Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy. BMJ Open 2020;10:e038123. [PMID: 32928858 DOI: 10.1136/bmjopen-2020-038123] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
86 Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Hepatitis B vaccination during pregnancy for preventing infant infection. Cochrane Database Syst Rev 2011;:CD007879. [PMID: 21412913 DOI: 10.1002/14651858.CD007879.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
87 Peng S, Wan Z, Liu T, Zhu H, Du Y. Incidence and Risk Factors of Intrauterine Transmission Among Pregnant Women With Chronic Hepatitis B Virus Infection. J Clin Gastroenterol 2019;53:51-7. [PMID: 29517711 DOI: 10.1097/MCG.0000000000001001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]